Correlation Between Esperion Therapeutics and Origin Materials

Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Origin Materials at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Origin Materials into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Esperion Therapeutics and Origin Materials, you can compare the effects of market volatilities on Esperion Therapeutics and Origin Materials and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Origin Materials. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Origin Materials.

Diversification Opportunities for Esperion Therapeutics and Origin Materials

-0.73

Correlation Coefficient

Esperion Therapeutics  Origin Materials

Pay attention - limited upside

The 3 months correlation between Esperion and Origin is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Origin Materials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Origin Materials and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Origin Materials. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Origin Materials has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Origin Materials go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and Origin Materials

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.16 times more return on investment than Origin Materials. However, Esperion Therapeutics is 1.16 times more volatile than Origin Materials. It trades about 0.44 of its potential returns per unit of risk. Origin Materials is currently generating about -0.02 per unit of risk. If you would invest  200.00  in Esperion Therapeutics on September 4, 2024 and sell it today you would earn a total of  125.00  from holding Esperion Therapeutics or generate 62.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Esperion Therapeutics  vs.  Origin Materials

Esperion Therapeutics

Risk-Adjusted Performance

16 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Origin Materials

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Origin Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Esperion Therapeutics and Origin Materials

The main advantage of trading using opposite Esperion Therapeutics and Origin Materials positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Origin Materials can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Origin Materials will offset losses from the drop in Origin Materials' long position.

The idea behind Esperion Therapeutics and Origin Materials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.